1-7 of 7
J. Milburn Jessup
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Free
Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff, Caroline C. Sigman, Hervé Avet-Loiseau, Ann T. Farrell, Nicole J. Gormley, Shaji K. Kumar, Ola Landgren, Nikhil C. Munshi, Michele Cavo, Faith E. Davies, Alessandra Di Bacco, Jennifer S. Dickey, Steven I. Gutman, Howard R. Higley, Mohamad A. Hussein, J. Milburn Jessup, Ilan R. Kirsch, Richard F. Little, Robert D. Loberg, Jens G. Lohr, Lata Mukundan, James L. Omel, Trevor J. Pugh, Gregory H. Reaman, Michael D. Robbins, A. Kate Sasser, Nancy Valente, Elena Zamagni
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 3980–3993.
https://doi.org/10.1158/1078-0432.CCR-16-2895
Published: 01 August 2017
View articletitled, The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Open the PDF for The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications in another window
Includes: Supplementary data
Journal Articles

Inhibition of NANOG/NANOGP8 Downregulates MCL-1 in Colorectal Cancer Cells and Enhances the Therapeutic Efficacy of BH3 Mimetics

Free
Abid R. Mattoo, Jingyu Zhang, Luis A. Espinoza, J. Milburn Jessup
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (21): 5446–5455.
https://doi.org/10.1158/1078-0432.CCR-14-1134
Published: 30 October 2014
View articletitled, Inhibition of NANOG/NANOGP8 Downregulates MCL-1 in Colorectal Cancer Cells and Enhances the Therapeutic Efficacy of BH3 Mimetics
Open the PDF for Inhibition of NANOG/NANOGP8 Downregulates MCL-1 in Colorectal Cancer Cells and Enhances the Therapeutic Efficacy of BH3 Mimetics in another window
Includes: Supplementary data
Journal Articles

Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer

Free
David R. Parkinson, Robert T. McCormack, Susan M. Keating, Steven I. Gutman, Stanley R. Hamilton, Elizabeth A. Mansfield, Margaret A. Piper, Patricia DeVerka, Felix W. Frueh, J. Milburn Jessup, Lisa M. McShane, Sean R. Tunis, Caroline C. Sigman, Gary J. Kelloff
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1428–1444.
https://doi.org/10.1158/1078-0432.CCR-13-2961
Published: 13 March 2014
View articletitled, Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer
Open the PDF for Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer in another window
Journal Articles

Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development

Free
George Poste, David P. Carbone, David R. Parkinson, Jaap Verweij, Stephen M. Hewitt, J. Milburn Jessup
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1515–1523.
https://doi.org/10.1158/1078-0432.CCR-11-2206
Published: 14 March 2012
View articletitled, Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development
Open the PDF for Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development in another window
Journal Articles

Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use

Free
P. Michael Williams, Tracy G. Lively, J. Milburn Jessup, Barbara A. Conley
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1531–1539.
https://doi.org/10.1158/1078-0432.CCR-11-2203
Published: 14 March 2012
View articletitled, Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use
Open the PDF for Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use in another window
Journal Articles

Lessons Learned from the Investigational Device Exemption Review of Children's Oncology Group Trial AAML1031

Free
Soheil Meshinchi, Stephen P. Hunger, Richard Aplenc, Peter C. Adamson, J. Milburn Jessup
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1547–1554.
https://doi.org/10.1158/1078-0432.CCR-11-2205
Published: 14 March 2012
View articletitled, Lessons Learned from the Investigational Device Exemption Review of Children's Oncology Group Trial AAML1031
Open the PDF for Lessons Learned from the Investigational Device Exemption Review of Children's Oncology Group Trial AAML1031 in another window
Journal Articles

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

Free
Janet E. Dancey, Kevin K. Dobbin, Susan Groshen, J. Milburn Jessup, Andrew H. Hruszkewycz, Maria Koehler, Ralph Parchment, Mark J. Ratain, Lalitha K. Shankar, Walter M. Stadler, Lawrence D. True, Amy Gravell, Michael R. Grever
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1745–1755.
https://doi.org/10.1158/1078-0432.CCR-09-2167
Published: 14 March 2010
View articletitled, Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
Open the PDF for Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents in another window